Published in Int J Cancer on October 01, 2010
Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs. Sleep Med Rev (2015) 1.39
Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol (2015) 1.24
Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med (2014) 1.20
Targeting hypoxic tumour cells to overcome metastasis. BMC Cancer (2011) 1.19
Intermittent hypoxemia and OSA: implications for comorbidities. Chest (2015) 1.17
Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success. Cancer Cell (2012) 1.10
The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol (2014) 1.04
Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells. PLoS One (2012) 0.94
Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia (2010) 0.93
Circulating tumor cells in the central and peripheral venous compartment - assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Onco Targets Ther (2014) 0.88
Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells. World J Gastroenterol (2012) 0.84
Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia. Oncotarget (2015) 0.84
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) (2015) 0.84
Here come the sleep apnea-cancer studies. Sleep (2013) 0.83
Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells. Onco Targets Ther (2013) 0.82
Putative Links Between Sleep Apnea and Cancer: From Hypotheses to Evolving Evidence. Chest (2015) 0.82
Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia (2014) 0.82
Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia. PLoS One (2014) 0.82
Optimizing hypoxia detection and treatment strategies. Semin Nucl Med (2015) 0.81
Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors. Tumor Microenviron Ther (2013) 0.81
DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts. BMC Cancer (2014) 0.79
Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation. Am J Clin Oncol (2012) 0.79
Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo. Neoplasia (2015) 0.79
Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol (2011) 0.79
Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques. Strahlenther Onkol (2011) 0.78
Clinical implications of cellular stress responses. Bosn J Basic Med Sci (2012) 0.77
RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors. Clin Epigenetics (2016) 0.77
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma. BMC Cancer (2014) 0.76
Molecular mechanisms of hypoxia in cancer. Clin Transl Imaging (2017) 0.75
Development of a mathematical model to estimate intra-tumor oxygen concentrations through multi-parametric imaging. Biomed Eng Online (2016) 0.75
Pathophysiological Basis for the Formation of the Tumor Microenvironment. Front Oncol (2016) 0.75
The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles. Transl Oncol (2017) 0.75
Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS. Neoplasia (2015) 0.75
Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia. Oncotarget (2017) 0.75
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res (2006) 3.10
Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res (2007) 2.40
Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res (2002) 1.26
The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res (2005) 1.23
Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res (2002) 1.08
A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber. Microvasc Res (2007) 1.02
Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Clin Cancer Res (2010) 0.96
Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery. Photochem Photobiol (2008) 0.93
Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia (2010) 0.93
High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts. PLoS One (2012) 0.91
Radiocurability is associated with interstitial fluid pressure in human tumor xenografts. Neoplasia (2009) 0.91
Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2011) 0.90
Dynamic contrast-enhanced-MRI of tumor hypoxia. Magn Reson Med (2011) 0.89
Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol (2009) 0.87
Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia (2008) 0.87
Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI. Radiat Res (2008) 0.86
Thrombospondin-1 treatment prevents growth of dormant lung micrometastases after surgical resection and curative radiation therapy of the primary tumor in human melanoma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.85
Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images. Radiat Res (2009) 0.84
Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol (2011) 0.84
Magnetic resonance imaging of tumor necrosis. Acta Oncol (2010) 0.84
Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology. Radiother Oncol (2010) 0.84
Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors. Radiother Oncol (2010) 0.83
Development of hypoxia in a preclinical model of tumor micrometastases. Int J Radiat Oncol Biol Phys (2010) 0.83
pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts. Int J Radiat Oncol Biol Phys (2012) 0.83
Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts. Acta Oncol (2012) 0.83
Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI. Acta Oncol (2013) 0.82
Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI. J Magn Reson Imaging (2007) 0.82
Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol (2011) 0.81
Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn Reson Med (2006) 0.81
DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts. BMC Cancer (2014) 0.79
Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts. Int J Radiat Oncol Biol Phys (2012) 0.78
Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol (2011) 0.77
Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry. Radiat Res (2008) 0.77
Interstitial fluid pressure and vascularity of intradermal and intramuscular human tumor xenografts. Int J Radiat Oncol Biol Phys (2011) 0.76
Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys (2009) 0.76
Vascular abnormalities associated with acute hypoxia in human melanoma xenografts. Radiother Oncol (2012) 0.76
Tumor-line specific causes of intertumor heterogeneity in blood supply in human melanoma xenografts. Microvasc Res (2012) 0.76